Shuttle Pharmaceuticals Holdings, Inc. Announces Reverse Stock Split and Amendment to Certificate of Incorporation
Key Highlights
- Reverse Stock Split Approved and Implemented: Shuttle Pharmaceuticals Holdings, Inc. (“Shuttle Pharma” or “the Company”) has executed a material amendment to its Certificate of Incorporation, enacting a reverse stock split of its common stock.
- Shareholder Approval: The reverse stock split was authorized by shareholders at the Company’s annual meeting held on May 21, 2026.
- Effective Date: The reverse stock split became effective with the opening of trading on June 11, 2026.
- Trading Information: Following the split, Shuttle Pharma’s common stock continues to trade on The Nasdaq Capital Market under the symbol “SHPH”. The new CUSIP number for the post-split shares is 825693500.
- Amendment to Articles of Incorporation: The Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the State of Delaware, formalizing the reverse stock split.
- Emerging Growth Company: Shuttle Pharma continues to qualify as an “emerging growth company” under SEC regulations, which may allow for certain regulatory relief and compliance flexibility.
Details of the Reverse Stock Split
At the annual meeting of stockholders held on May 21, 2026, Shuttle Pharmaceuticals Holdings, Inc. received shareholder approval authorizing the Board of Directors to implement a reverse stock split of the Company’s common stock. This corporate action was subsequently enacted via a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation filed in the State of Delaware.
The reverse stock split became effective at the opening of trading on The Nasdaq Capital Market on June 11, 2026. As a result, all issued and outstanding shares of common stock were adjusted according to the reverse split ratio approved by shareholders and determined by the Board. The specific ratio was not disclosed in this filing, but the adjustment impacts the number of shares held by stockholders and the price per share.
The Company’s common stock continues to trade under the ticker symbol “SHPH”, and the new CUSIP number assigned to shares after the split is 825693500.
Potential Impact on Shareholders and Share Price
- Shareholder Value and Outstanding Shares: A reverse stock split reduces the number of outstanding shares and increases the per-share price proportionally, but does not affect the total market value of shareholders’ holdings. However, the perception of a higher share price can often influence investor sentiment and trading activity.
- Nasdaq Compliance: Reverse stock splits are often used by companies to regain compliance with minimum bid price rules for continued listing on the Nasdaq. Maintaining a listing can be vital for liquidity, investor access, and institutional investment.
- Price Sensitivity: While the split itself does not change the value held by shareholders, it can have a significant impact on the share price due to market psychology or technical factors. Investors should monitor trading activity following the split for increased volatility.
- Amended Corporate Charter: The amendment to the Certificate of Incorporation is a material event and is available as Exhibit 3.1 to the SEC filing. Investors may wish to review the full text for further details, especially regarding the split ratio and any additional changes to shareholder rights.
- Emerging Growth Company Status: Shuttle Pharma remains an emerging growth company, which may provide flexibility in financial reporting and regulatory compliance but also means the company is still in a developmental or early commercial stage.
Other Notable Information
- No Other Material Corporate Actions Disclosed: The filing confirms that there are no concurrent written communications under Rule 425 (Securities Act), soliciting materials under Rule 14a-12 (Exchange Act), or pre-commencement tender offers under Rules 14d-2(b) or 13e-4(c) of the Exchange Act.
- Exhibits: The full Certificate of Amendment is included as Exhibit 3.1 to the report. The filing also includes an interactive data file with cover information.
What Should Investors Watch For?
- Share Price Movement: Reverse splits can trigger increased volatility as the market digests the new share price and float. Investors should expect higher-than-average trading volume in the days following the effective date.
- Nasdaq Compliance: The reverse split may be a direct response to maintain or regain Nasdaq listing standards. Continued compliance is critical to ensuring ongoing trading liquidity and institutional investor access.
- Future Corporate Actions: This amendment provides the Board with increased flexibility for future corporate actions, including potential financing activities, mergers, or further adjustments to the capital structure.
- Review Full Amendment: For additional details—including any potential changes to shareholder rights or preferred stock—investors are encouraged to review the complete Certificate of Amendment as filed.
Disclaimer
The information provided in this article is intended for informational purposes only and does not constitute investment advice or an offer to buy or sell securities. Investors should perform their own due diligence and consult with a qualified financial advisor before making any investment decisions. The author and publisher are not responsible for investment actions taken based on the information provided.
